MorphoSys Targets 2020 Tafasitamab Launch Following Good DLBCL Data

 
• By Sten Stovall
Lymphoma
L-MIND Combined MOR208 And Lenalidomide In r/r DLBCL Patients • Source: Shutterstock

More from Clinical Trials

More from R&D